PV Watch Daily Blog
Fresh reporting, analysis, and expert insight on drug safety, regulatory developments, safety signals, inspections, AI in pharmacovigilance, and career trends.
Week in PV: FDA B6 Warning, GLP-1 Label Change and PRAC Updates
This week’s major U.S. developments include FDA’s requirement for a vitamin B6 deficiency and seizure warning on carbidopa/levodopa products and the agency’s...
EMA’s ESMP Training Push Signals More Structured Shortage Reporting
EMA’s upcoming events page lists European Shortages Monitoring Platform (ESMP) training on readable IDs and general updates for industry on 14 April 2026. EMA...
Why Regulators Are Building Always-On Safety Information Hubs
FDA’s AEMS pages include a public dashboard and a standing page for new safety information or potential signals of serious risks. FDA also maintains a 2026...
CVMP March 2026 Highlights Keep Veterinary Safety in View
EMA published meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) for 10–12 March 2026 and noted that the committee meeting was...
Why Regulators Are Building Always-On Safety Information Hubs
FDA’s AEMS pages include a public dashboard and a standing page for new safety information or potential signals of serious risks. FDA also maintains a 2026...
CVMP March 2026 Highlights Keep Veterinary Safety in View
EMA published meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) for 10–12 March 2026 and noted that the committee meeting was...
EMA’s ESMP Training Push Signals More Structured Shortage Reporting
EMA’s upcoming events page lists European Shortages Monitoring Platform (ESMP) training on readable IDs and general updates for industry on 14 April 2026. EMA...
EMA Adds Anktiva to Additional Monitoring List in March 2026
EMA’s March 2026 additional monitoring update says Anktiva was added to the list as a new active substance, new biological, and conditionally authorised...
Rabies Immunoglobulin Recall Follows Potency Stability Failure
MHRA says Bio Products Laboratory Limited is recalling one batch of Human Rabies Immunoglobulin 500 IU solution for injection after a stability failure caused...
FDA Warns 30 Telehealth Firms Over Compounded GLP-1 Claims
FDA announced on 3 March 2026 that it issued 30 warning letters to telehealth companies for making false or misleading claims regarding compounded GLP-1...